A detailed history of Genesis Private Wealth, LLC transactions in Abbott Laboratories stock. As of the latest transaction made, Genesis Private Wealth, LLC holds 2,697 shares of ABT stock, worth $350,690. This represents 0.1% of its overall portfolio holdings.

Number of Shares
2,697
Previous 2,630 2.55%
Holding current value
$350,690
Previous $352 Million 4.07%
% of portfolio
0.1%
Previous 0.15%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2025

Jan 08, 2026

BUY
$123.62 - $134.59 $8,282 - $9,017
67 Added 2.55%
2,697 $338 Million
Q3 2025

Oct 08, 2025

BUY
$120.51 - $136.62 $964 - $1,092
8 Added 0.31%
2,630 $352 Million
Q2 2025

Jul 17, 2025

BUY
$123.95 - $138.08 $13,014 - $14,498
105 Added 4.17%
2,622 $357 Million
Q1 2025

Apr 23, 2025

BUY
$111.1 - $140.22 $6,777 - $8,553
61 Added 2.48%
2,517 $334 Million
Q4 2024

Jan 17, 2025

BUY
$111.93 - $119.39 $274,900 - $293,221
2,456 New
2,456 $278 Million

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $228B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Genesis Private Wealth, LLC Portfolio

Follow Genesis Private Wealth, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Genesis Private Wealth, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Genesis Private Wealth, LLC with notifications on news.